Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Translational Stroke Research
Published in: Translational Stroke Research 4/2010

01-12-2010

Proteomic Identification of Novel Plasma Kallikrein Substrates in the Astrocyte Secretome

Authors: Jia Liu, Ben-Bo Gao, Edward P. Feener

Published in: Translational Stroke Research | Issue 4/2010

Login to get access

Abstract

Plasma kallikrein (PK) is activated during hemorrhage and has been implicated in cerebral vascular permeability and edema. To further characterize the potential effects of PK on the brain that may follow cerebral vascular injury, we have utilized a proteomics approach to search for novel PK substrates in the astrocyte secretome. Extracellular proteins released by astrocytes are critical mediators of cerebral homeostasis, including roles in synapse function and vascular integrity. We identified 1,108 proteins in astrocyte condition medium and 295 of these were annotated as secreted proteins. The total abundance of nine proteins was changed after treatment with PK. Characterization of the secreted proteins revealed low molecular weight fragments for 59 proteins in conditioned media exposed to PK that were not observed in untreated controls. The most striking finding from this study was the appearance of fragmentation of 26 extracellular matrix-associated proteins including collagen isoforms 1–6 and11, nidogen-1 and -2, lysyl oxidase-like protein 1, and matrix metalloproteinase 19 in the presence of PK. We also demonstrated that PK induced the fragmentation of non-matrix proteins, including apolipoprotein E. This report further characterizes the astrocyte secretome and identifies novel potential targets of PK-induced proteolysis that may contribute to its effects on the brain following vascular injury.
Appendix
Available only for authorised users
Literature
1.
Knight RA, Han Y, Nagaraja TN, Whitton P, Ding J, Chopp M, et al. Temporal MRI assessment of intracerebral hemorrhage in rats. Stroke. 2008;39:2596–602.CrossRefPubMed
2.
Durukan A, Marinkovic I, Strbian D, Pitkonen M, Pedrono E, Soinne L, et al. Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI. Brain Res. 2009;1280:158–65.CrossRefPubMed
3.
Weiss N, Miller F, Cazaubon S, Couraud PO. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta. 2009;1788:842–57.CrossRefPubMed
4.
Taheri S, Candelario-Jalil E, Estrada EY, Rosenberg GA. Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke. PLoS ONE. 2009;4:e6597.CrossRefPubMed
5.
6.
Maurer MH. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom Rev. 2010;29:17–28.PubMed
7.
Park KP, Rosell A, Foerch C, Xing C, Kim WJ, Lee S, et al. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke. 2009;40:2836–42.CrossRefPubMed
8.
McColl BW, Rose N, Robson FH, Rothwell NJ, Lawrence CB. Increased brain microvascular mmp-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke. J Cereb Blood Flow Metab. 2010;30:267–72.CrossRefPubMed
9.
Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab. 2000;20:755–64.CrossRefPubMed
10.
Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001;7:59–64.CrossRefPubMed
11.
Echeverry R, Wu J, Haile WB, Guzman J, Yepes M. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest. 2010;120:2194–205.CrossRefPubMed
12.
Gao BB, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007;13:181–8.CrossRefPubMed
13.
Storini C, Bergamaschini L, Gesuete R, Rossi E, Maiocchi D, De Simoni MG. Selective inhibition of plasma kallikrein protects brain from reperfusion injury. J Pharmacol Exp Ther. 2006;318:849–54.CrossRefPubMed
14.
Schmaier AH, McCrae KR. The plasma kallikrein-kinin system: its evolution from contact activation. J Thromb Haemost. 2007;5:2323–9.CrossRefPubMed
15.
Sainz IM, Pixley RA, Colman RW. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb Haemost. 2007;98:77–83.PubMed
16.
Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, et al. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 2006;25:2686–97.CrossRefPubMed
17.
Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol. 2001;3:267–75.CrossRefPubMed
18.
Abid K, Rochat B, Lassahn PG, Stocklin R, Michalet S, Brakch N, et al. Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3–35: a new peptide generated by plasma kallikrein. J Biol Chem. 2009;284:24715–24.CrossRefPubMed
19.
Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci. 2007;10:1369–76.CrossRefPubMed
20.
Halassa MM, Haydon PG. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol. 2010;72:335–55.CrossRefPubMed
21.
Bauer H, Stelzhammer W, Fuchs R, Weiger TM, Danninger C, Probst G, et al. Astrocytes and neurons express the tight junction-specific protein occludin in vitro. Exp Cell Res. 1999;250:434–8.CrossRefPubMed
22.
Siddharthan V, Kim YV, Liu S, Kim KS. Human astrocytes/astrocyte-conditioned medium and shear stress enhance the barrier properties of human brain microvascular endothelial cells. Brain Res. 2007;1147:39–50.CrossRefPubMed
23.
Gao BB, Stuart L, Feener EP. Label-free quantitative analysis of 1D-page LC/MS/MS proteome: application on angiotensin II stimulated smooth muscle cells secretome. Mol Cell Proteomics. 2008;7:2399–409.CrossRefPubMed
24.
Camon E, Barrell D, Lee V, Dimmer E, Apweiler R. The gene ontology annotation (GOA) database—an integrated resource of GO annotations to the uniprot knowledgebase. In Silico Biol. 2004;4:5–6.PubMed
25.
Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, et al. The gene ontology (GO) database and informatics resource. Nucleic Acids Res. 2004;32:D258–61.CrossRefPubMed
26.
Emanuelsson O, Nielsen H, Brunak S, von Heijne G. Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol. 2000;300:1005–16.CrossRefPubMed
27.
Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 2004;340:783–95.CrossRefPubMed
28.
Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305:567–80.CrossRefPubMed
29.
Lewin MF, Kaplan AP, Harpel PC. Studies of c1 inactivator-plasma kallikrein complexes in purified systems and in plasma. J Biol Chem. 1983;258:6415–21.PubMed
30.
Takano T, Oberheim N, Cotrina ML, Nedergaard M. Astrocytes and ischemic injury. Stroke. 2009;40:S8–12.CrossRefPubMed
31.
Nakagawa T, Schwartz JP. Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes. Neurochem Int. 2004;45:203–42.CrossRefPubMed
32.
Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276–87.CrossRefPubMed
33.
Lafon-Cazal M, Adjali O, Galeotti N, Poncet J, Jouin P, Homburger V, et al. Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J Biol Chem. 2003;278:24438–48.CrossRefPubMed
34.
Delcourt N, Jouin P, Poncet J, Demey E, Mauger E, Bockaert J, et al. Difference in mass analysis using labeled lysines (DIMAL-K): a new, efficient proteomic quantification method applied to the analysis of astrocytic secretomes. Mol Cell Proteomics. 2005;4:1085–94.CrossRefPubMed
35.
Keene SD, Greco TM, Parastatidis I, Lee SH, Hughes EG, Balice-Gordon RJ, et al. Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics. 2009;9:768–82.CrossRefPubMed
36.
Moore NH, Costa LG, Shaffer SA, Goodlett DR, Guizzetti M. Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation. J Neurochem. 2009;108:891–908.CrossRefPubMed
37.
Dowell JA, Johnson JA, Li L. Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. J Proteome Res. 2009;8:4135–43.CrossRefPubMed
38.
Yan H, Zhou W, Wei L, Zhong F, Yang Y. Proteomic analysis of astrocytic secretion that regulates neurogenesis using quantitative amine-specific isobaric tagging. Biochem Biophys Res Commun. 2010;391:1187–91.CrossRefPubMed
39.
Greco TM, Seeholzer SH, Mak A, Spruce L, Ischiropoulos H. Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J Proteome Res. 2010;9:2764–74.CrossRefPubMed
40.
Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 2008;39:1121–6.CrossRefPubMed
41.
Scholler K, Trinkl A, Klopotowski M, Thal SC, Plesnila N, Trabold R, et al. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res. 2007;1142:237–46.CrossRefPubMed
42.
Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med. 2006;354:1489–96.CrossRefPubMed
43.
Vahedi K, Kubis N, Boukobza M, Arnoult M, Massin P, Tournier-Lasserve E, et al. COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke. 2007;38:1461–4.CrossRefPubMed
44.
Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC, et al. Mutations in COL4A1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005;308:1167–71.CrossRefPubMed
45.
Beck IM, Ruckert R, Brandt K, Mueller MS, Sadowski T, Brauer R, et al. MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses. PLoS ONE. 2008;3:e2343.CrossRefPubMed
46.
Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36:178–82.CrossRefPubMed
47.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–3.CrossRefPubMed
48.
Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer’s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci USA. 2003;100:10966–71.CrossRefPubMed
49.
Tolar M, Keller JN, Chan S, Mattson MP, Marques MA, Crutcher KA. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci. 1999;19:7100–10.PubMed
50.
Marques MA, Owens PA, Crutcher KA. Progress toward identification of protease activity involved in proteolysis of apolipoprotein E in human brain. J Mol Neurosci. 2004;24:73–80.CrossRefPubMed
51.
Zhou W, Scott SA, Shelton SB, Crutcher KA. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer’s disease. Neuroscience. 2006;143:689–701.CrossRefPubMed
Metadata
Title
Proteomic Identification of Novel Plasma Kallikrein Substrates in the Astrocyte Secretome
Authors
Jia Liu
Ben-Bo Gao
Edward P. Feener
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Translational Stroke Research / Issue 4/2010
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-010-0039-z

Other articles of this Issue 4/2010

Translational Stroke Research 4/2010 Go to the issue

Review Article

Toll-Like Receptor Tolerance as a Mechanism for Neuroprotection

Omics, Markers, and Mechanisms

Opportunities and Challenges in Omics

Review

Genetics Studies in Ischaemic Stroke

OriginalPaper

MicroRNAs in Cerebral Ischemia

OriginalPaper

Assessing the Quality and Reproducibility of a Proteomic Platform for Clinical Stroke Biomarker Discovery

Review

Astroglial Proteins as Diagnostic Markers of Acute Intracerebral Hemorrhage—Pathophysiological Background and Clinical Findings